Literature DB >> 36175825

Temporal Pattern of Neuroinflammation Associated with a Low Glycemic Index Diet in the 5xFAD Mouse Model of Alzheimer's Disease.

Ioannis Dafnis1, Christina Mountaki1, Eleni Fanarioti2, Dimitrios C Mastellos3, Michalis Karvelas4, Vaios T Karathanos4,5, Athina Tzinia1, Catherine R Dermon2, Angeliki Chroni6.   

Abstract

Alzheimer's disease (AD) is associated with brain amyloid-β (Aβ) peptide accumulation and neuroinflammation. Currants, a low glycemic index dried fruit, and their components display pleiotropic neuroprotective effects in AD. We examined how diet containing 5% Corinthian currant paste (CurD) administered in 1-month-old 5xFAD mice for 1, 3, and 6 months affects Aβ levels and neuroinflammation in comparison to control diet (ConD) or sugar-matched diet containing 3.5% glucose/fructose (GFD). No change in serum glucose or insulin levels was observed among the three groups. CurD administered for 3 months reduced brain Aβ42 levels in male mice as compared to ConD and GFD, but after 6 months, Aβ42 levels were increased in mice both on CurD and GFD compared to ConD. CurD for 3 months also reduced TNFα and IL-1β levels in male and female mouse cortex homogenates compared to ConD and GFD. However, after 6 months, TNFα levels were increased in cortex homogenates of mice both on CurD and GFD as compared to ConD. A similar pattern was observed for TNFα-expressing cells, mostly co-expressing the microglial marker CD11b, in mouse hippocampus. IL-1β levels were similarly increased in the brain of all groups after 6 months. Furthermore, a time dependent decrease of secreted TNFα levels was found in BV2 microglial cells treated with currant phenolic extract as compared to glucose/fructose solution. Overall, our findings suggest that a short-term currant consumption reduces neuroinflammation in 5xFAD mice as compared to sugar-matched or control diet, but longer-term intake of currant or sugar-matched diet enhances neuroinflammation.
© 2022. The Author(s).

Entities:  

Keywords:  Alzheimer’s disease; Low glycemic index diet; Microglia; Neuroinflammation; TNFα

Year:  2022        PMID: 36175825     DOI: 10.1007/s12035-022-03047-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.682


  61 in total

Review 1.  Immune attack: the role of inflammation in Alzheimer disease.

Authors:  Frank L Heppner; Richard M Ransohoff; Burkhard Becher
Journal:  Nat Rev Neurosci       Date:  2015-06       Impact factor: 34.870

Review 2.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

3.  Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: A double-blinded placebo controlled pilot study.

Authors:  Jooyeon Lee; Nare Torosyan; Daniel H Silverman
Journal:  Exp Gerontol       Date:  2016-11-14       Impact factor: 4.032

Review 4.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

Authors:  Tony Wyss-Coray
Journal:  Nat Med       Date:  2006-09       Impact factor: 53.440

Review 5.  Alzheimer's disease: Abeta, tau and synaptic dysfunction.

Authors:  Frank M LaFerla; Salvatore Oddo
Journal:  Trends Mol Med       Date:  2005-04       Impact factor: 11.951

Review 6.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 7.  Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease.

Authors:  Madhuri Venigalla; Sandra Sonego; Erika Gyengesi; Matthew J Sharman; Gerald Münch
Journal:  Neurochem Int       Date:  2015-10-31       Impact factor: 3.921

Review 8.  Synergy between amyloid-β and tau in Alzheimer's disease.

Authors:  Marc Aurel Busche; Bradley T Hyman
Journal:  Nat Neurosci       Date:  2020-08-10       Impact factor: 24.884

9.  Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers.

Authors:  Qiushan Tao; Ting Fang Alvin Ang; Charles DeCarli; Sanford H Auerbach; Sheral Devine; Thor D Stein; Xiaoling Zhang; Joseph Massaro; Rhoda Au; Wei Qiao Qiu
Journal:  JAMA Netw Open       Date:  2018-10-05

Review 10.  Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus.

Authors:  Brianne M Bettcher; Malú G Tansey; Guillaume Dorothée; Michael T Heneka
Journal:  Nat Rev Neurol       Date:  2021-09-14       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.